POLYESTER SUTURE 2830-23

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,06 report with the FDA on 1996-12-04 for POLYESTER SUTURE 2830-23 manufactured by Cyanimid Canada, Inc..

Event Text Entries

[35826] During a procedure for strabismus, the tip of the catheter needle bent easily as soon as the needle came in contact with the sclera. The doctor immediately removed the needle from the sclera at this point, and noted a tiny barb near the bending area. Subsequently, he examined the eye with an ophthalmoscope, and found no perforation in the sclera. Post-operatively, the pt has been doing well. No evidence of scleral perforation one month post-op.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1627446-1996-00010
MDR Report Key53877
Report Source01,06
Date Received1996-12-04
Date of Report1996-11-05
Date of Event1996-10-24
Date Facility Aware1996-10-24
Report Date1996-11-05
Date Reported to Mfgr1996-11-05
Date Mfgr Received1996-11-05
Device Manufacturer Date1994-11-01
Date Added to Maude1996-12-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePOLYESTER SUTURE
Generic NameSURGICAL SUTURE
Product CodeHMN
Date Received1996-12-04
Model NumberNA
Catalog Number2830-23
Lot Number4K0744
ID NumberNA
Device Expiration Date1999-09-01
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Age24 MO
Device Eval'ed by MfgrY
Implant FlagY
Date RemovedA
Device Sequence No1
Device Event Key54464
ManufacturerCYANIMID CANADA, INC.
Manufacturer Address19400 TRANS CANADA HWY BAIE D'URFE, QUEBEC CA H9X 3N7


Patients

Patient NumberTreatmentOutcomeDate
10 1996-12-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.